Brief: Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
23/06/2025 12:46
June 23 (Reuters) - Carisma Therapeutics Inc CARM.O: CARISMA THERAPEUTICS AND ORTHOCELLIX ENTER INTO DEFINITIVE MERGER AGREEMENT TO CREATE COMPANY FOCUSED ON REGENERATIVE CELL THERAPIES FOR ORTHOPEDIC DISEASES CARISMA THERAPEUTICS INC - ORTHOCELLIX TO MERGE INTO WHOLLY-OWNED SUBSIDIARY OF CARISMA CARISMA THERAPEUTICS INC - ORTHOCELLIX STOCKHOLDER TO OWN 90% OF COMBINED COMPANY POST-MERGER CARISMA THERAPEUTICS INC - TO BE RENAMED ORTHOCELLIX AND TRADE UNDER TICKER OCLX CARISMA THERAPEUTICS: TO ISSUE TO PRE-MERGER ORTHOCELLIX STOCKHOLDER SHARES OF CO'S COMMON STOCK AS MERGER CONSIDERATION Source text: ID:nGNX6g7bnR Further company coverage: CARM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Carisma Therapeutics
See all newsBrief: Carisma Therapeutics & Modernatx Amend Collaboration & And License Agreement - SEC Filing
Carisma Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Carisma Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
Carisma Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary